Anti-Obesity Drugs Market to Grow with a Substantial CAGR of 21% on the Back of Growing Demand for Obesity Treatment during 2019-2027

Research Nester released a report titled “Anti-Obesity Drugs Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global anti-obesity drugs market in terms of market segmentation by mechanism of action, by distribution channel and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Obesity, a disorder that results from excessive body fat, leads to the development of various health disorders such as diabetes, cardiovascular disease and other physical disabilities. The market for anti-obesity drugs is anticipated to record a CAGR of around 21% over the forecast period, i.e., 2019-2027. The market is segmented by mechanism of action, by distribution channel and by region, out of which, the mechanism of action segment is further bifurcated into peripherally acting anti-obesity drugs and centrally acting anti-obesity drugs. The drugs which include the central nervous system as a part of their mechanism of action are centrally acting anti-obesity drugs while others that produce no effects on the brain and spinal cord are peripherally acting anti-obesity drugs.

Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-23

The market in North America is anticipated to hold the largest share in the anti-obesity drugs market. This can be attributed to the high prevalence of obesity in the region, especially in the United States. The growing healthcare expenditure and increasing approval of anti-obesity drugs further contribute towards the market growth. On the other hand, the market in the Asia Pacific region is predicted to grow at the highest rate during the forecast period on account of growing incidences of diabetes and other such disorders which are associated with obesity.

Growing Awareness about Obesity and Associated Health Disorders to Propel the Market Growth

According to the World Health Organization, over 1.9 billion adults (aged 18 and above) were found to be overweight in 2016. Out of these, more than 650 million people were obese, which was about 13% of adults globally. Further, more than 340 million children and adolescents between the ages 5 to 19 and about 41 million children under the age of 5 were found to be overweight or obese in the same year. The rising awareness about the health risks linked with obesity is a major growth driving factor for the anti-obesity drugs market. However, the side effects of anti-obesity drugs including stroke, mental illness and other undesired health conditions are estimated to hamper the market growth during the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global anti-obesity drugs market which includes company profiling of F. Hoffmann-La Roche (SWX: ROG), GlaxoSmithKline plc. (LON: GSK), Takeda Pharmaceutical Company Limited (TYO: 4502), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Boehringer Ingelheim International GmbH, Eisai Co., Ltd. (TYO: 4523), Novo Nordisk (CPH: NOVO-B), Pfizer Inc. (NYSE: PFE), Rhythm Pharmaceuticals, Inc. and Shionogi Inc. (TYO: 4507). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global anti-obesity drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Read More Information@ https://www.researchnester.com/reports/anti-obesity-drugs-market/23

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:

AJ Daniel

Email: sales@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919